Peptide Atlas · Peptide

Cetrorelix

Cetrorelix is a decapeptide GnRH (LHRH) antagonist: unlike agonists it suppresses LH and FSH at once, without an initial surge, by competitive receptor blockade; after phase III trials in IVF it became the first LHRH antagonist approved for clinical use.

established

provisional
PubChem 25074887
2 citations
0 discussions
0 followers
Cetrorelix acetate
Cetrotide
GnRH antagonist
SB-75

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Cetrorelix. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
A single cetrorelix injection prevented LH surges in IVF stimulation	emerging	pmid 9806259
Review: cetrorelix, the first clinically approved LHRH antagonist	established	pmid 10972520

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.